CYTK(Cytokinetics, Incorporated) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $70.43M | $94.59M | $7.53M | $18.47M | $88.04M |
| 毛利润 | — | — | — | — | — |
| 营业利润 | −$186.31M | −$324.20M | −$496.20M | −$536.25M | −$612.26M |
| 净利润 | −$215.31M | −$388.95M | −$526.24M | −$589.53M | −$784.96M |
| 经营现金流 | −$142.52M | −$299.52M | −$414.33M | −$395.89M | −$510.01M |
| 自由现金流 | −$191.39M | −$310.85M | −$415.75M | −$399.80M | −$534.82M |
| 摊薄每股收益 | $-2.80 | $-4.33 | $-5.45 | $-5.26 | $-6.54 |